The production of interferon-γ-inducible protein 10 by granulocytes and monocytes is associated with ulcerative colitis disease activity
- 89 Downloads
To clarify which types of cells produce interferon-γ-inducible protein 10 (IP-10) and whether IP-10 is associated with the development of ulcerative colitis (UC), we investigated IP-10 production in UC patients.
Serum IP-10 levels were measured using enzyme-linked immunosorbent assay in 29 patients with active and 21 with inactive UC and in 20 controls. The production of IP-10 by granulocytes and monocytes adsorbed to G-1 beads was examined. In 21 active UC patients treated with granulocyte and monocyte/macrophage adsorptive apheresis (GMA), serum IP-10 levels were measured before and after treatment. IP-10-positive cells in UC mucosa were also examined immunohistochemically using tissues obtained by surgical resection and colonoscopic biopsies.
Serum IP-10 levels in active UC patients were significantly higher than those in inactive patients, although even in the latter the levels were increased compared with those in controls. IP-10 production by granulocytes and monocytes in active UC patients was significantly higher than that in controls. Furthermore, the number of IP-10-positive cells was elevated in the colonic mucosa of patients with active UC, and one of the main subpopulations of IP-10-positive cells was granulocytes. Serum IP-10 levels decreased following GMA treatment in responders, but not in nonresponders. Interestingly, serum IP-10 levels before GMA were higher in responders than in nonresponders. In parallel with the serum levels, IP-10-positive cells also decreased following GMA treatment.
Serum IP-10 levels reflected UC disease activity, and the source of IP-10 was granulocytes and monocytes. Furthermore, serum IP-10 levels may be a marker for the responsiveness of patients to GMA treatment.
Key wordsulcerative colitis IP-10 adsorptive apheresis granulocyte monocyte
Unable to display preview. Download preview PDF.
- 9.Gasperini, S, Marchi, M, Calzetti, F, Laudanna, C, Vicentini, L, Olsen, H, et al. 1999Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophilsJ Immunol162492837PubMedGoogle Scholar
- 10.Hamilton, NH, Banyer, JL, Hapel, AJ, Mahalingam, S, Ramsay, AJ, Ramshaw, IA, et al. 2002IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE)Scand J Immunol551717PubMedGoogle Scholar
- 33.Saniabadi, AR, Hanai, H, Suzuki, Y, Ohmori, T, Sawada, K, Yoshimura, N, et al. 2005Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?J Clin Apher2017184PubMedCrossRefGoogle Scholar
- 49.Biswas, P, Mantelli, B, Hasson, H, Vecchi, A, Saniabadi, A, Lazzarin, A, et al. 2003In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: implications for treatment of HIV infection and other immune disordersClin Immunol1093558PubMedCrossRefGoogle Scholar